Abstract:AIM:To clone human high mobility guoup box1 A box (HMGB1 A box) and express it in escherichia coli effectly, investigate the inhibit effection of the purpose protern to the activation of monocytes stimulated by immunocomplex.METHODS:According to human HMGB1 gene order which was optimized by our laboratory the PCR primer was designed which containing restriction enzyme cutting site. The HMGB1 A box gene was cloned following the whole gene synthesis template of human HMGB1, then the PCR product was inserted into clone vector pMD19-T. The positive colone was identified by colony PCR, zymography analysis and DNA sequencing. Recombinant colne vector was digested by restriction enzymes Nde I and Xho I and separated by agarose gel electrophoresis, then the fragment was inserted into the corresponding sites of expression vector pQE-T7-2. The positive recombinant expression vector was identified by colony PCR and the recombinant strains was induced by IPTG, then the purpose protein was identified by SDS-PAGE and Western blot. The recombinant protein of human HMGB1 A box was purificated by Ni(2+)-NTA chromatography and the inhibit effection of the purpose protern to the activation of monocyte stimulated by immunocomplex was identified by RT-PCR.RESULTS:We acquired expression strains of recombinant human HMGB1 A box, the target protein account for up to 40% of the whole protein of E.coli. Western blot showed recombinant protein can specificly reacted with anti-human HMGB1 polyclonal antibody and anti-His-Tag polyclonal antibody.The purpose protein was found more than 90% after purified, and can effectively inhibit the production of BAFF, IFN-gamma and TNF-alpha in monocyte which were induced by IC.CONCLUSION:A recombinant bacterial strain for expressing human HMGB1A box with biological activities was constructed successfully.

HMGN2: a novel antimicrobial effector molecule of human mononuclear leukocytes?

Isolation and Purification of HMGN2 from Human Monocyte Cell Line THP-1 and Its Antimicrobial Activity

HMGN2: an Antitumor Effector Molecule of Γδt Cells

HMGN2 Protein Inhibits the Growth of Infected T24 Cells in Vitro.

Nucleosome-binding protein HMGN2 exhibits antitumor activity in oral squamous cell carcinoma.

[Application of HMGN2-tag Constructs to Analysis of HMGN2 Distribution in HeLa Cells].

Cloning and Expression of Human Beta-Defensin-2 Gene in Escherichia Coli

Hemolysin Sph2 from Leptospira interrogans amplified inflammatory response in murine macrophages J774A.1 through HMGB1

The chromosomal protein HMGN2 mediates lipopolysaccharide-induced expression of β-defensins in A549 cells

Inhibitory effect of HMGN2 protein on human hepatitis B viral HBeAg and HBsAg expression and DNA replication in HBV-transformed HepG2. 2.15 cell line

Analysis of the released nuclear cytokine HMGB1 in human serum.

High-mobility Group Nucleosome-binding Protein and It's Potential Clinical Uses

[Expression of Human HMGB1 A Box in E. Coli and Its Inhibitory Effects on Monocytes].

Identification, Recombinant Expression, and Characterization of LGH2, a Novel Antimicrobial Peptide of Lactobacillus Casei HZ1

Increased Expression of High-Mobility Group Nucleosomal-Binding Domain 2 Protein in Various Tumor Cell Lines.

Prokaryotic Expression and Activity Identification of Hybrid Peptide HMCM

ZL-2, a Cathelicidin-Derived Antimicrobial Peptide, Has a Broad Antimicrobial Activity Against Gram-Positive Bacteria and Gram-Negative Bacteria in Vitro and in Vivo

A Novel ML Protein Functions As a Pattern Recognition Protein in Antibacterial Responses in Eriocheir Sinensis.

High Mobility Group Box-1 Protein Plays an Important Role in Transcription and Expression of Interleukin-2 Mediated by Nuclear Factor of Activated T Cells-2

Analysis of Circulating HMGB1 in Human Serum

Identification of Ly2 members as antimicrobial peptides from zebrafish Danio rerio.